Why India's Pharma Sector Remains Unstoppable Despite U.S. Tariff Concerns | Gaurang Shah Explains

India's pharmaceutical industry continues to dominate the global healthcare market despite fresh tariff concerns from the US. Gaurang Shah, Sr. VP, Geojit Investments, believes India will remain the "pharmacy to the world" for years due to its strong manufacturing capabilities, research, and product innovation. He advises investors to look beyond pharma manufacturers and also focus on hospitals and diagnostic companies, which together form the broader healthcare ecosystem.